Top Markets
Coin of the day
Zhejiang Garden Biopharmaceutical Co.,Ltd. Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401
Rangering i aksjer #8798
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and... Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3. Zhejiang Garden Biopharmaceutical Co.,Ltd. was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.
Aksjekurs
$2.14
Sist synkronisert: 2026-08-28
Markedsverdi
$1.17B
Endring (1 dag)
-2.63%
Endring (1 år)
1.42%
Land
CN
Handel Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401)

Kategori

Inntekter for Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401)
Inntekter i 2026 TTM: 0
Ifølge Zhejiang Garden Biopharmaceutical Co.,Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Zhejiang Garden Biopharmaceutical Co.,Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter